MODERATE TO SEVERE PLAQUE PSORIASIS
Clinical trials for MODERATE TO SEVERE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks how long psoriasis drug works in kids
Disease control OngoingThis study follows children aged 6 to 17 with moderate-to-severe plaque psoriasis who are taking secukinumab. Researchers want to see how long patients stay on the drug and how well it controls their symptoms. The study does not test a new treatment but observes real-world use of…
Matched conditions: MODERATE TO SEVERE PLAQUE PSORIASIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 11:31 UTC
-
Psoriasis drug study dives into genetic changes
Knowledge-focused OngoingThis study looks at how the drug bimekizumab affects gene activity in people with moderate to severe plaque psoriasis, with or without psoriatic arthritis. Researchers will take small skin samples to measure changes in gene expression over 48 weeks. The goal is to better understa…
Matched conditions: MODERATE TO SEVERE PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated May 26, 2026 11:34 UTC